Exploitation of CD3ζ to enhance TCR expression levels and antigen-specific T cell function.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2024
Historique:
received: 14 02 2024
accepted: 16 05 2024
medline: 14 6 2024
pubmed: 14 6 2024
entrez: 14 6 2024
Statut: epublish

Résumé

The expression levels of TCRs on the surface of human T cells define the avidity of TCR-HLA/peptide interactions. In this study, we have explored which components of the TCR-CD3 complex are involved in determining the surface expression levels of TCRs in primary human T cells. The results show that there is a surplus of endogenous TCR α/β chains that can be mobilised by providing T cells with additional CD3γ,δ,ε,ζ chains, which leads to a 5-fold increase in TCR α/β surface expression. The analysis of individual CD3 chains revealed that provision of additional ζ chain alone was sufficient to achieve a 3-fold increase in endogenous TCR expression. Similarly, CD3ζ also limits the expression levels of exogenous TCRs transduced into primary human T cells. Interestingly, transduction with TCR plus CD3ζ not only increased surface expression of the introduced TCR, but it also reduced mispairing with endogenous TCR chains, resulting in improved antigen-specific function. TCR reconstitution experiments in HEK293T cells that do not express endogenous TCR or CD3 showed that TCRα/β and all four CD3 chains were required for optimal surface expression, while in the absence of CD3ζ the TCR expression was reduced by 50%. Together, the data show that CD3ζ is a key regulator of TCR expression levels in human T cells, and that gene transfer of exogenous TCR plus CD3ζ improved TCR surface expression, reduced TCR mispairing and increased antigen-specific function.

Identifiants

pubmed: 38873603
doi: 10.3389/fimmu.2024.1386132
pmc: PMC11169823
doi:

Substances chimiques

CD3 Complex 0
CD3 antigen, zeta chain 0
Receptors, Antigen, T-Cell 0
Receptors, Antigen, T-Cell, alpha-beta 0
Receptor-CD3 Complex, Antigen, T-Cell 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1386132

Informations de copyright

Copyright © 2024 Degirmencay, Thomas, Holler, Burgess, Morris and Stauss.

Déclaration de conflit d'intérêts

Author HS is co-founder of Quell Therapeutics, and has a consultant contract and shares. He also has shares in Kuur Therapeutics and is scientific advisor for Pan CancerT. EM is co-founder and share holder of Quell Therapeutics. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Abdullah Degirmencay (A)

Institute of Immunity and Transplantation, Division of Infection and Immunity, University College London, Pears Building, London, United Kingdom.

Sharyn Thomas (S)

Institute of Immunity and Transplantation, Division of Infection and Immunity, University College London, Pears Building, London, United Kingdom.

Angelika Holler (A)

Institute of Immunity and Transplantation, Division of Infection and Immunity, University College London, Pears Building, London, United Kingdom.

Samuel Burgess (S)

Institute of Immunity and Transplantation, Division of Infection and Immunity, University College London, Pears Building, London, United Kingdom.

Emma C Morris (EC)

Institute of Immunity and Transplantation, Division of Infection and Immunity, University College London, Pears Building, London, United Kingdom.

Hans J Stauss (HJ)

Institute of Immunity and Transplantation, Division of Infection and Immunity, University College London, Pears Building, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH